Brain, behavior, and immunity · 2026
Epigenetic C-reactive protein and corticolimbic gray matter volume in youth at clinical high risk for psychosis.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ku Benson S, Xu Ying, Goldsmith David R, Sawyers Chelsea, Addington Jean, Bearden Carrie E, Cadenhead Kristin S, Cannon Tyrone D, Carrion Ricardo E, Keshavan Matcheri S, Mathalon Daniel H, Stone William S, Woods Scott W, Walker Elaine F, Perkins Diana O, Bozack Anne K
Аннотация
AIMS: Inflammation and structural brain alterations are implicated in psychosis risk, yet it remains unknown whether epigenetic C-reactive protein (CRP), a DNA methylation-based estimator of cumulative inflammatory burden, is associated with brain structure in youth at clinical high risk for psychosis (CHR-P).
METHODS: We examined associations between epigenetic and plasma CRP, regional gray matter volume (GMV), and positive symptom severity in 165 participants (108 CHR-P, 57 healthy comparisons (HC)) from the North American Prodrome Longitudinal Study Phase 2. Epigenetic CRP was derived from the Illumina 450 k array; plasma CRP was quantified in a subset of 81 participants via multiplex immunoassay. GMVs of the medial prefrontal cortex, anterior cingulate cortex (ACC), and hippocampus were extracted from 3-Tesla MRI scans; positive symptoms were assessed with the Scale of Prodromal Symptoms.
RESULTS: Epigenetic and plasma CRP were weakly correlated (r = 0.19). Higher epigenetic CRP was associated with lower GMV in several corticolimbic regions, including the left caudal ACC (β = - 0.08, p = 0.011), and lower cACC volume was associated with greater positive symptom severity (β = - 0.26, p = 0.001). Plasma CRP showed no significant associations in the primary combined-sample model.
CONCLUSIONS: To our knowledge, this study is the first to show that epigenetic CRP is associated with corticolimbic structural differences in CHR-P and HC youth. Epigenetic CRP may capture inflammation-related neurostructural variation relevant to psychosis risk.
METHODS: We examined associations between epigenetic and plasma CRP, regional gray matter volume (GMV), and positive symptom severity in 165 participants (108 CHR-P, 57 healthy comparisons (HC)) from the North American Prodrome Longitudinal Study Phase 2. Epigenetic CRP was derived from the Illumina 450 k array; plasma CRP was quantified in a subset of 81 participants via multiplex immunoassay. GMVs of the medial prefrontal cortex, anterior cingulate cortex (ACC), and hippocampus were extracted from 3-Tesla MRI scans; positive symptoms were assessed with the Scale of Prodromal Symptoms.
RESULTS: Epigenetic and plasma CRP were weakly correlated (r = 0.19). Higher epigenetic CRP was associated with lower GMV in several corticolimbic regions, including the left caudal ACC (β = - 0.08, p = 0.011), and lower cACC volume was associated with greater positive symptom severity (β = - 0.26, p = 0.001). Plasma CRP showed no significant associations in the primary combined-sample model.
CONCLUSIONS: To our knowledge, this study is the first to show that epigenetic CRP is associated with corticolimbic structural differences in CHR-P and HC youth. Epigenetic CRP may capture inflammation-related neurostructural variation relevant to psychosis risk.